SMTS
SMTS Somanetics beats by $0.03; raises FY06 EPS guidance, reaffirms rev guidance (20.26 )
Reports Q3 (Aug) earnings of $0.13 per share, $0.03 better than the Reuters Estimates consensus of $0.10; revenues rose 50.2% year/year to $7.9 mln vs the $7.6 mln consensus. Co raises EPS guidance for FY06, to EPS of $0.47-0.49 from $0.40-0.42 vs. $0.44 consensus; reaffirms FY06 rev growth guidance of +50% or roughly $30 mln vs $29.5 mln consensus... Co also signs contract development and licensing agreement for several novel tecgnologies
وهذا السهم لاصحاب الشورت
GVHR
GVHR Gevity lowers guidance for Q3 & Q4 and FY06 (24.23 )
Co issues downside guidance for Q3 (Sep), sees EPS of at least $0.27, down from $0.36-0.38 vs. $0.37 Reuters Estimates consensus; sees Q3 (Sep) revs of $158-162 mln down from $169-179 mln vs. $170.76 mln consensus. Co issues downside guidance for Q4 (Dec), sees EPS of at least $0.38 down from $0.41-0.43 vs. $0.41 consensus; sees Q4 (Dec) revs of $167-177 mln down from $183-193 vs. $181.03 mln consensus. Co issues downside guidance for FY06 (Dec), sees EPS of at least $1.31, down from $1.43-1.47 vs. $1.43 consensus; see FY06 (Dec) rev growth of 8-10%, down from 12-15% or roughly current expectations of $664-676.6 mln vs. $676.02 mln consensus.
SMTS Somanetics beats by $0.03; raises FY06 EPS guidance, reaffirms rev guidance (20.26 )
Reports Q3 (Aug) earnings of $0.13 per share, $0.03 better than the Reuters Estimates consensus of $0.10; revenues rose 50.2% year/year to $7.9 mln vs the $7.6 mln consensus. Co raises EPS guidance for FY06, to EPS of $0.47-0.49 from $0.40-0.42 vs. $0.44 consensus; reaffirms FY06 rev growth guidance of +50% or roughly $30 mln vs $29.5 mln consensus... Co also signs contract development and licensing agreement for several novel tecgnologies
وهذا السهم لاصحاب الشورت
GVHR
GVHR Gevity lowers guidance for Q3 & Q4 and FY06 (24.23 )
Co issues downside guidance for Q3 (Sep), sees EPS of at least $0.27, down from $0.36-0.38 vs. $0.37 Reuters Estimates consensus; sees Q3 (Sep) revs of $158-162 mln down from $169-179 mln vs. $170.76 mln consensus. Co issues downside guidance for Q4 (Dec), sees EPS of at least $0.38 down from $0.41-0.43 vs. $0.41 consensus; sees Q4 (Dec) revs of $167-177 mln down from $183-193 vs. $181.03 mln consensus. Co issues downside guidance for FY06 (Dec), sees EPS of at least $1.31, down from $1.43-1.47 vs. $1.43 consensus; see FY06 (Dec) rev growth of 8-10%, down from 12-15% or roughly current expectations of $664-676.6 mln vs. $676.02 mln consensus.
